Motion DNA Takes Biomechanics Testing Public

***

Business Editors SCOTTSDALE, Ariz.--(BUSINESS WIRE)--MOTD-- Motion DNA Corporation has become a new publicly traded company effective January 30, 2004 (Pink Sheets:MOTD). The board of directors unanimously agreed to take the company public on the OTC in a meeting held January 19, 2004. Zig Ziegler, Motion DNA - President commented, "Now that we are a publicly traded company we have access to the resources to drive growth for our shareholders. The completion of the initial public offering is the first step in a series of activities that will continue to position Motion DNA as a premier medical service provider around the world. Our plans include several key acquisitions and strategic partnerships over the next eleven months as we strive towards our revenue projections of just over $8 million for 2004." Motion DNA Corporation provides diagnostic testing for medical professionals and sports organizations. The company's patented software and hardware systems have been used globally by some of the world's leading health care practitioners, biomechanical research institutions and professional sports agencies. Motion DNA's co-branded biomechanical analyses and detailed reports provide its customers and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing pre-existing injuries related to biomechanics, and improving physical performance levels. The company plans to further penetrate the sports world through scheduled diagnostic tests of major league baseball players and other elite athletes beginning in February. In addition, Motion DNA will launch a new division targeting the personal injury market; potentially impacting insurance expenses in the multi-billion dollar market. This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products, which we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. KEYWORD: ARIZONA INDUSTRY KEYWORD: MEDICAL DEVICES BIOTECHNOLOGY SOFTWARE HARDWARE IPO SOURCE: Motion DNA Corporation CONTACT INFORMATION: Hewlett Investor Relations Troy Levy, 954-933-9005 Hewlettir@comcast.net

Motion DNA Corp. Brings Leadership to Sales and Marketing Team
SCOTTSDALE, Ariz., Mar 15, 2004 (BUSINESS WIRE) --
Motion DNA Corp. has named Charles Baker senior vice president of sales and marketing. Before joining Motion DNA Corp., Baker served 23 years as executive director of sales for Bankers Systems Inc. He was responsible for leading the success of his team of 58 salespeople.

Said Baker about the future of Motion DNA Corp., "We have only yet reached the tip of the iceberg. In the very near future, we will not only be able to benefit those in the athletic and medical rehabilitation fields, but we will also be able to affect the ergonomics of many different jobs in many different industries -- leading to both efficiency and preventative healthcare measures in the workplace."

Prior to his work in sales, Baker coached track and field at both the high school and collegiate levels. The highlight of his coaching career began in 1969 at Indiana University, where he coached until 1973. Baker coached numerous top track and field athletes including former 400 meter dash world record holder Lee Evans. Today, he continues to referee collegiate track and field meets across the nation.

Motion DNA Corp. provides diagnostic testing for medical professionals and sports organizations. The company's patented software and hardware systems have been used globally by some of the world's leading health care practitioners, biomechanical research institutions and professional sports agencies. Motion DNA's biomechanical analyses and detailed reports provide its corporate customers and general consumers with solutions for preventing injuries, identifying physical limitations, diagnosing pre-existing injuries related to biomechanics, and improving physical performance levels.

SOURCE: Motion DNA Corp.

I think if they play their cards right, this one has blue chip potential down the road.

quote:

---

Originally posted by Jeremy:
This one was incredibly easy to make money on this morning. Bought at .26 and sold at .28 10 minutes later, bought more at .26 and sold again at .285 about 20 minutes later

Looks like it won't see much over .3 today, but I'll be ready to do the same thing again tomorrow

---

"Our board of advisors is crucial to gaining respect and credibility within each of the markets we service," said Zig Ziegler, president of Motion DNA. "The board will help to facilitate the launch of our technology into thousands of medical practices and businesses around the country."

Ziegler also stated, "The executive board of advisors will be a valuable asset, assisting the company in developing strategies for implementing our analysis into the workplace. Employees of shipping and manual labor companies suffer unnecessary injuries each year, costing companies billions of dollars in medical expense and workers compensation. Our technology may help make the companies' repetitive job assignments more efficient, as we conduct research for automakers, packaging companies and mail delivery service employees."

The sports medicine board of advisors will act to validate technology, conduct research, and create product awareness in their respective fields. Selections of board members are expected to be announced by the end of the week.

In other company news, Motion DNA is preparing to launch a new interactive Web site. The site is designed, created in part by Phoenix-based Oculus Networks and Internet fitness pioneer Dan Wirth. Once completed, the site will include one of the world's most complete rehab and fitness exercise prescription tools. Patients of Motion DNA will receive their detailed Motion DNA Analysis and immediately be able to activate a link through their Internet browser, which takes them to customized exercise and rehab protocols.

"Today's therapists conduct subjective tests on patients followed by hours of program planning and implementation of basic protocols," said Ziegler. "This tool is designed to make the job of the physical therapist, sports coach, or other practitioner easier, potentially cutting actual planning time down to seconds."

This site is also expected to generate additional revenue for the company as well as its current and future corporate customers and strategic partners.

Motion DNA's Web-based exercise and rehab tool is scheduled to be linked to the company's other analysis products. Once completed, the prescription of exercises will be automated and immediately available. The protocols will be based on the results of the Motion DNA 3D-Analysis. For product information, contact the Motion DNA corporate offices, 480-425-7734 or visit www.motiondnacorp.com.

Motion DNA Corp. provides diagnostic testing for medical professionals and sports organizations. The company's patented software and hardware systems have been used globally by some of the world's leading health care practitioners, biomechanical research institutions and professional sports agencies. Motion DNA's biomechanical analyses and detailed reports provide its customers and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing pre-existing injuries related to biomechanics, and improving physical performance levels.

SOURCE: Motion DNA Corp.

Developed weeks ahead of schedule, the BioTrainer(TM) utilizes software developed by Motion DNA for the InterSense IC-2 and IC-3 motion tracking cubes. Unlike other current technologies, the BioTrainer(TM) does not require clients to move within a magnetic field, making it the first of its kind as the world's only true free motion tracking device for physical therapy.

Designed as a biofeedback tool, the new BioTrainer(TM) will allow physical therapists to conduct rehabilitation with fewer limiting restrictions. The therapist can provide less direct supervision to the patient, with the assurance that exercises are being conducted correctly. The new technology allows patients to self-correct inaccurate movements, as a tone rings from the BioTrainer(TM) when the exercise is performed to the correct specifications set by the therapist.

Said Ziegler, "This technology is essential to physical therapists and their patients. With the BioTrainer(TM), therapists can make certain that the exercises are being performed by the patient in the correct manner, every time."

Ziegler also stated, "In a typical therapy session, patients conduct many of their exercises under partial supervision. The BioTrainer(TM) will act as an additional employee for a fraction of the cost. The BioTrainer(TM) immediately lets the patient and therapist know if the exercise is being performed correctly and efficiently."

Through the end of the second quarter, use of the BioTrainer(TM) is only available from Motion DNA as a service. Beginning next week, approximately 10,000 units will be available for sale and delivery in the third quarter of 2004. Motion DNA will also continue to use its current technology, the Polhemus Fastrak and Liberty, offering full diagnostic assessments for sports and fitness.

The BioTrainer(TM) will be demonstrated at next week's International Health, Racquet and Sports Club Association annual convention and trade show in Las Vegas. More than 10,000 health club owners, physical therapists, athletic trainers, and medical professionals are expected to visit the trade show at the annual convention, seeking the latest tools available for health and fitness.

Motion DNA anticipates sales of 1,000 units priced at $1,995 over the next 90 days. For product information, contact the Motion DNA corporate offices, 480-425-7734 or visit www.motiondnacorp.com.

Motion DNA Corp. provides diagnostic testing for medical professionals and sports organizations. The company's patented software and hardware systems have been used globally by some of the world's leading health care practitioners, biomechanical research institutions and professional sports agencies. Motion DNA's biomechanical analyses and detailed reports provide its customers and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing pre-existing injuries related to biomechanics, and improving physical performance levels.

SOURCE: Motion DNA Corp.